Similar Items: The role of TBX2 and the anti-cancer activity of chromomycin A5 in pancreatic ductal adenocarcinoma
- Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma
- Thromboembolic Risks in Pancreatic Ductal Adenocarcinoma: A Review of Anatomical and Clinical Variations
- Multifunctional PLGA Nanoparticles: pH-Triggered Drug Release for Pancreatic Ductal Adenocarcinoma
- Association of tumor associated collagen signature with lymph node metastasis in pancreatic ductal adenocarcinoma
- An Unusual Case of Pancreatic Ductal Adenocarcinoma With Synchronous Rectal Metastasis in a Younger Female
- Prognostic Significance of Portal Vein Tumor Thrombus in Pancreatic Ductal Adenocarcinoma Treated With Chemoradiotherapy
Author: Prince, Sharon
- Identification and characterization of a novel Palladacycle, AJ-5, to treat advanced Melanoma and breast Cancer
- The role of TBX2 and the anti-cancer activity of chromomycin A5 in pancreatic ductal adenocarcinoma
- The role of the transcription factor TBX2 in breast cancer and melanoma and its regulation by the UV-induced DNA damage pathway.
- Regulation of the cyclin-dependent kinase inhibitor p21 by TBX3
- Identifying novel drugs for the treatment of rhabdomyosarcoma
- The role of T-box transcription factor TBX3 in rhabdomyosarcoma